Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci F, Iulita MF, Pentz R, Flores Aguilar L, Orciani C, Barone C, Romano C, Drago F, Cuello AC.

Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5.

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia

Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchhardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J.

Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.

Data Platform for the Research and Prevention of Alzheimer's Disease

An N, Jin L, Yang J, Yin Y, Jiang S, Jing B, Au R.

Adv Exp Med Biol. 2017;1028:55-78. doi: 10.1007/978-981-10-6041-0_4.

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

Lautner R, Insel PS, Skillbäck T, Olsson B, Landén M, Frisoni GB, Herukka SK, Hampel H, Wallin A, Minthon L, Hansson O, Blennow K, Mattsson N, Zetterberg H.

Alzheimers Res Ther. 2017 Oct 23;9(1):87. doi: 10.1186/s13195-017-0313-3.

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A.

Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.

Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.

Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.

Recent Progress in the Pharmacotherapy of Alzheimer's Disease

Khoury R, Patel K, Gold J, Hinds S, Grossberg GT.

Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X.

Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

Alzheimer's disease: evolution of research diagnostic criteria

The Lancet Neurology.

Lancet Neurol. 2017 Dec;16(12):945. doi: 10.1016/S1474-4422(17)30376-9. Epub 2017 Nov 14.

The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results

de Mauléon A, Soto M, Kiyasova V, Delrieu J, Guignot I, Galtier S, Lilamand M, Cantet C, Lala F, Sastre N, Andrieu S, Pueyo M, Ousset PJ, Vellas B.

J Prev Alzheimers Dis. 2017;4(3):183-193. doi: 10.14283/jpad.2017.8.

The Role of Chromatography in Alzheimer's Disease Drug Discovery

Fiori J, De Simone A, Naldi M, Andrisano V.

Adv Chromatogr. 2017;53:75-107.

GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease

Li JQ, Wang HF, Zhu XC, Sun FR, Tan MS, Tan CC, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2017 Jan;54(1):146-153. doi: 10.1007/s12035-015-9669-1. Epub 2016 Jan 5.

Impact of functional alterations on quality of life in patients with Alzheimer's disease

Barbe C, Morrone I, Wolak-Thierry A, Dramé M, Jolly D, Novella JL, Mahmoudi R.

Aging Ment Health. 2017 May;21(5):571-576. doi: 10.1080/13607863.2015.1132674. Epub 2016 Jan 8.

Dopamine transporter imaging as a diagnostic modality for atypical Alzheimer's disease mimicking corticobasal degeneration

Washida K, Kowa H, Yamamoto Y, Kanda F, Toda T.

Psychogeriatrics. 2017 Jan;17(1):73-75. doi: 10.1111/psyg.12184. Epub 2016 Jan 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias